These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7310604)

  • 21. Pharmacokinetics and pharmacodynamics of d-tubocurarine and metocurine in the elderly.
    Matteo RS; Backus WW; McDaniel DD; Brotherton WP; Abraham R; Diaz J
    Anesth Analg; 1985 Jan; 64(1):23-9. PubMed ID: 3966648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The dose-effect relationship of metocurine: EMG versus MMG.
    Eisenkraft JB
    Anesthesiology; 1988 Nov; 69(5):807-8. PubMed ID: 2973267
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacokinetics and pharmacodynamics of metocurine in humans with and without renal failure.
    Brotherton WP; Matteo RS
    Anesthesiology; 1981 Sep; 55(3):273-6. PubMed ID: 7023284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuromuscular paralysis for newborn infants receiving mechanical ventilation.
    Cools F; Offringa M
    Cochrane Database Syst Rev; 2000; (4):CD002773. PubMed ID: 11034760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative haemodynamic effects of tubocurarine and metocurine in the dog.
    Antonio RP; Philbin DM; Savarese JJ
    Br J Anaesth; 1979 Nov; 51(11):1007-10. PubMed ID: 518800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pancuronium, unlike other nondepolarizing relaxants, retains potency at hypothermia.
    Horrow JC; Bartkowski RR
    Anesthesiology; 1983 Apr; 58(4):357-61. PubMed ID: 6220624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of parametric with semiparametric analysis of the concentration versus effect relationship of metocurine in dogs and pigs.
    Shafer SL; Varvel JR; Gronert GA
    J Pharmacokinet Biopharm; 1989 Jun; 17(3):291-304. PubMed ID: 2810069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized trial of moderately early low-dose dexamethasone therapy in very low birth weight infants: dynamic pulmonary mechanics, oxygenation, and ventilation.
    Durand M; Mendoza ME; Tantivit P; Kugelman A; McEvoy C
    Pediatrics; 2002 Feb; 109(2):262-8. PubMed ID: 11826205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multicenter controlled clinical trial of high-frequency jet ventilation in preterm infants with uncomplicated respiratory distress syndrome.
    Keszler M; Modanlou HD; Brudno DS; Clark FI; Cohen RS; Ryan RM; Kaneta MK; Davis JM
    Pediatrics; 1997 Oct; 100(4):593-9. PubMed ID: 9310511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Provo multicenter early high-frequency oscillatory ventilation trial: improved pulmonary and clinical outcome in respiratory distress syndrome.
    Gerstmann DR; Minton SD; Stoddard RA; Meredith KS; Monaco F; Bertrand JM; Battisti O; Langhendries JP; Francois A; Clark RH
    Pediatrics; 1996 Dec; 98(6 Pt 1):1044-57. PubMed ID: 8951252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metocurine pharmacokinetics and pharmacodynamics in goats.
    Antognini JF; Wood R; Gronert GA
    J Vet Pharmacol Ther; 1995 Dec; 18(6):464-7. PubMed ID: 8789701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased sensitivity to metocurine in patients with upper motoneuron disease.
    Shayevitz JR; Matteo RS
    Anesth Analg; 1985 Aug; 64(8):767-72. PubMed ID: 3160262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vecuronium and d-tubocurarine combination: potentiation of effect.
    Mirakhur RK; Gibson FM; Ferres CJ
    Anesth Analg; 1985 Jul; 64(7):711-4. PubMed ID: 2861763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potentiation of the combination of pancuronium and metocurine by halothane and isoflurane in humans with and without renal failure.
    Bennett MJ; Hahn JF
    Anesthesiology; 1985 Jun; 62(6):759-64. PubMed ID: 4003796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of respiratory-induced acid-base changes on the action of non-depolarizing muscle relaxants in rats.
    Ono K; Ohta Y; Morita K; Kosaka F
    Anesthesiology; 1988 Mar; 68(3):357-62. PubMed ID: 2894186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The dose-effect relationship of metocurine: the integrated electromyogram of the first dorsal interosseous muscle and the mechanomyogram of the adductor pollicis compared.
    Kopman AF
    Anesthesiology; 1988 Apr; 68(4):604-7. PubMed ID: 3354898
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacodynamics and pharmacokinetics of metocurine in humans: comparison to d-tubocurarine.
    Matteo RS; Brotherton WP; Nishitateno K; Khambatta HJ; Dias J
    Anesthesiology; 1982 Sep; 57(3):183-90. PubMed ID: 6287887
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of maintenance dose vecuronium on pre-established metocurine- or vecuronium-induced neuromuscular blockade.
    Ornstein E; Matteo RS; Weinstein JA; Young WL
    Anesthesiology; 1988 Dec; 69(6):954-5. PubMed ID: 2904233
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical characteristics and outcomes of respiratory distress syndrome in term and late-preterm neonates].
    Chen A; Shi LP; Zheng JY; Du LZ
    Zhonghua Er Ke Za Zhi; 2008 Sep; 46(9):654-7. PubMed ID: 19099850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased sensitivity to metocurine during long-term phenytoin therapy may be attributable to protein binding and acetylcholine receptor changes.
    Kim CS; Arnold FJ; Itani MS; Martyn JA
    Anesthesiology; 1992 Sep; 77(3):500-6. PubMed ID: 1519788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.